PropertyValue
?:abstract
  • Curative Inc , created in January 2020 with the intent of improving diagnostics for sepsis, pivoted to SARS-CoV-2 testing in March 2020 as it became clear that the United States needed additional testing capacity Cell Systems spoke with Curative cofounders Fred Turner, Dr Isaac Turner, and Dr Vlad Slepnev about their work developing and deploying a COVID-19 oral fluid test at scale with unprecedented speed
?:creator
?:journal
  • Cell_Systems
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • COVID-19 Testing at Scale while Reimagining Healthcare: An Interview with Curative Cofounders Fred Turner, Isaac Turner, and Vlad Slepnev
?:type
?:who_covidence_id
  • #885220
  • #978236
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/ssqf3wgg>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/ssqf3wgg>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all